Synthesis and SAR studies of 3-phenoxypropyl piperidine analogues as ORL1 (NOP) receptor agonists

A series of potent and soluble ORL1 agonists was prepared and evaluated. Compound 41 showed antinociceptive properties in mouse formalin paw test (ED 50 = 1.07 μmol/kg). A series of 3-phenoxypropyl piperidine analogues have been discovered as novel ORL1 receptor agonists. Structure–activity relation...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Bioorganic & medicinal chemistry letters Ročník 15; číslo 3; s. 589 - 593
Hlavní autoři:	Palin, Ronald, Barn, David R., Clark, John K., Cottney, Jean E., Cowley, Phillip M., Crockatt, Marc, Evans, Louise, Feilden, Helen, Goodwin, Richard R., Griekspoor, Frank, Grove, Simon J.A., Houghton, Andrea K., Jones, Philip S., Morphy, Richard J., Smith, Alasdair R.C., Sundaram, Hardy, Vrolijk, David, Weston, Mark A., Wishart, Grant, Wren, Paul
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Oxford Elsevier Ltd 01.02.2005 Elsevier
Témata:	Analgesia Analgesics Animals Biological and medical sciences CHO Cells Cricetinae Cyclic AMP - biosynthesis Drug Design Humans Hydrophobic and Hydrophilic Interactions Inhibitory Concentration 50 Male Medical sciences Mice Neuropharmacology Nociception Opioid ORL1 Pharmacology. Drug treatments Piperidines - chemical synthesis Piperidines - pharmacology Receptors, Opioid - agonists Structure-Activity Relationship Transfection Vas Deferens Nociception Opioid Analgesia ORL1 Agonist Intravenous administration Rodentia Selectivity In vitro In vivo Vertebrata Mammalia Analgesic Structure activity relation Mouse Benzimidazole derivatives N/OFQ receptor Animal Piperidine derivatives Chemical synthesis
ISSN:	0960-894X, 1464-3405
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	A series of potent and soluble ORL1 agonists was prepared and evaluated. Compound 41 showed antinociceptive properties in mouse formalin paw test (ED 50 = 1.07 μmol/kg). A series of 3-phenoxypropyl piperidine analogues have been discovered as novel ORL1 receptor agonists. Structure–activity relationships have been explored around the 3-phenoxypropyl region with several potent and selective analogues identified.
AbstractList	A series of potent and soluble ORL1 agonists was prepared and evaluated. Compound 41 showed antinociceptive properties in mouse formalin paw test (ED 50 = 1.07 μmol/kg). A series of 3-phenoxypropyl piperidine analogues have been discovered as novel ORL1 receptor agonists. Structure–activity relationships have been explored around the 3-phenoxypropyl region with several potent and selective analogues identified. A series of 3-phenoxypropyl piperidine analogues have been discovered as novel ORL1 receptor agonists. Structure-activity relationships have been explored around the 3-phenoxypropyl region with several potent and selective analogues identified. A series of 3-phenoxypropyl piperidine analogues have been discovered as novel ORL1 receptor agonists. Structure-activity relationships have been explored around the 3-phenoxypropyl region with several potent and selective analogues identified.A series of 3-phenoxypropyl piperidine analogues have been discovered as novel ORL1 receptor agonists. Structure-activity relationships have been explored around the 3-phenoxypropyl region with several potent and selective analogues identified.
Author	Palin, Ronald Smith, Alasdair R.C. Morphy, Richard J. Clark, John K. Crockatt, Marc Vrolijk, David Barn, David R. Sundaram, Hardy Jones, Philip S. Feilden, Helen Goodwin, Richard R. Houghton, Andrea K. Grove, Simon J.A. Wren, Paul Weston, Mark A. Cowley, Phillip M. Evans, Louise Cottney, Jean E. Griekspoor, Frank Wishart, Grant
Author_xml	– sequence: 1 givenname: Ronald surname: Palin fullname: Palin, Ronald email: r.palin@organon.co.uk organization: Department of Medicinal Chemistry, Organon Laboratories Ltd, Newhouse, Lanarkshire ML1 5SH, UK – sequence: 2 givenname: David R. surname: Barn fullname: Barn, David R. organization: Department of Medicinal Chemistry, Organon Laboratories Ltd, Newhouse, Lanarkshire ML1 5SH, UK – sequence: 3 givenname: John K. surname: Clark fullname: Clark, John K. organization: Department of Medicinal Chemistry, Organon Laboratories Ltd, Newhouse, Lanarkshire ML1 5SH, UK – sequence: 4 givenname: Jean E. surname: Cottney fullname: Cottney, Jean E. organization: Department of Pharmacology, Organon Laboratories Ltd, Newhouse, Lanarkshire ML1 5SH, UK – sequence: 5 givenname: Phillip M. surname: Cowley fullname: Cowley, Phillip M. organization: Department of Medicinal Chemistry, Organon Laboratories Ltd, Newhouse, Lanarkshire ML1 5SH, UK – sequence: 6 givenname: Marc surname: Crockatt fullname: Crockatt, Marc organization: Department of Medicinal Chemistry, Organon Laboratories Ltd, Newhouse, Lanarkshire ML1 5SH, UK – sequence: 7 givenname: Louise surname: Evans fullname: Evans, Louise organization: Department of Pharmacology, Organon Laboratories Ltd, Newhouse, Lanarkshire ML1 5SH, UK – sequence: 8 givenname: Helen surname: Feilden fullname: Feilden, Helen organization: Department of Medicinal Chemistry, Organon Laboratories Ltd, Newhouse, Lanarkshire ML1 5SH, UK – sequence: 9 givenname: Richard R. surname: Goodwin fullname: Goodwin, Richard R. organization: Department of Medicinal Chemistry, Organon Laboratories Ltd, Newhouse, Lanarkshire ML1 5SH, UK – sequence: 10 givenname: Frank surname: Griekspoor fullname: Griekspoor, Frank organization: Department of Medicinal Chemistry, Organon Laboratories Ltd, Newhouse, Lanarkshire ML1 5SH, UK – sequence: 11 givenname: Simon J.A. surname: Grove fullname: Grove, Simon J.A. organization: Department of Medicinal Chemistry, Organon Laboratories Ltd, Newhouse, Lanarkshire ML1 5SH, UK – sequence: 12 givenname: Andrea K. surname: Houghton fullname: Houghton, Andrea K. organization: Department of Pharmacology, Organon Laboratories Ltd, Newhouse, Lanarkshire ML1 5SH, UK – sequence: 13 givenname: Philip S. surname: Jones fullname: Jones, Philip S. organization: Department of Medicinal Chemistry, Organon Laboratories Ltd, Newhouse, Lanarkshire ML1 5SH, UK – sequence: 14 givenname: Richard J. surname: Morphy fullname: Morphy, Richard J. organization: Department of Medicinal Chemistry, Organon Laboratories Ltd, Newhouse, Lanarkshire ML1 5SH, UK – sequence: 15 givenname: Alasdair R.C. surname: Smith fullname: Smith, Alasdair R.C. organization: Department of Medicinal Chemistry, Organon Laboratories Ltd, Newhouse, Lanarkshire ML1 5SH, UK – sequence: 16 givenname: Hardy surname: Sundaram fullname: Sundaram, Hardy organization: Department of Pharmacology, Organon Laboratories Ltd, Newhouse, Lanarkshire ML1 5SH, UK – sequence: 17 givenname: David surname: Vrolijk fullname: Vrolijk, David organization: Department of Medicinal Chemistry, Organon Laboratories Ltd, Newhouse, Lanarkshire ML1 5SH, UK – sequence: 18 givenname: Mark A. surname: Weston fullname: Weston, Mark A. organization: Department of Medicinal Chemistry, Organon Laboratories Ltd, Newhouse, Lanarkshire ML1 5SH, UK – sequence: 19 givenname: Grant surname: Wishart fullname: Wishart, Grant organization: Department of Medicinal Chemistry, Organon Laboratories Ltd, Newhouse, Lanarkshire ML1 5SH, UK – sequence: 20 givenname: Paul surname: Wren fullname: Wren, Paul organization: Department of Pharmacology, Organon Laboratories Ltd, Newhouse, Lanarkshire ML1 5SH, UK
BackLink	http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16478183$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/15664818$$D View this record in MEDLINE/PubMed
BookMark	eNp90UFr2zAYBmAxWta02x_YYeiy0R3sSfFn2YZdSunWQlhGu8FuQpY_tQqO5ErKWP79FJJS2KEnXZ5XfLzvKTly3iEh7zgrOePi86rs13os54xByXnJoHtFZhwEFBWw-ojMWCdY0Xbw-4ScxrhijAMDeE1OeC0EtLydEXW3dekBo41UuYHeXdzSmDaDxUi9oVUxPaDzf7dT8NN2pJOdMNjBOsxajf5-k52KdHm74PT8-_LHJxpQ45R8oOreOxtTfEOOjRojvj28Z-TX16ufl9fFYvnt5vJiUWiYt6ngugbQc-BQQ82EMT1DVQkYasUU12g6ANNXTYcKjclYD6qpDDbQVz0gVGfk4_7ffOtjvivJtY0ax1E59JsoRVM1NedVhu8PcNOvcZBTsGsVtvKplAw-HICKWo0mKKdtfHYCmh3Lbr53OvgYA5pnwuRuIbmSu4XkbiHJucwL5VD7X0jbpJL1LgVlx5ejX_ZRzDX-sRhk1BadxsHm1pMcvH0p_g8n9avN
CitedBy_id	crossref_primary_10_1016_j_bmcl_2014_07_069 crossref_primary_10_1016_j_bmcl_2009_09_028 crossref_primary_10_1016_j_tetasy_2006_10_014 crossref_primary_10_1016_j_tet_2008_01_125 crossref_primary_10_1016_j_bmc_2006_11_030 crossref_primary_10_1016_j_peptides_2006_07_011 crossref_primary_10_1002_adsc_201401164 crossref_primary_10_1213_01_ane_0000250403_88649_51 crossref_primary_10_1002_med_20197
Cites_doi	10.1016/j.bmcl.2003.09.068 10.1016/S0014-2999(97)01227-2 10.1002/cber.19851181037 10.1016/0169-328X(94)90181-3 10.1126/science.270.5237.792 10.1517/13543776.11.4.525 10.1038/377532a0 10.1055/s-1981-29317 10.1021/jm0209174 10.1016/S0040-4039(00)82103-6 10.1016/S0960-894X(02)00652-2 10.1016/0014-5793(94)00557-5 10.1016/S0040-4020(01)80962-5 10.1016/0167-0115(94)90431-6 10.1016/0014-5793(94)80235-1 10.1016/0304-3959(77)90130-0 10.1016/S0014-2999(00)00505-7 10.1517/13543776.10.4.371 10.1016/S0040-4020(00)01064-4 10.1021/jo981582u
ContentType	Journal Article
Copyright	2004 Elsevier Ltd 2005 INIST-CNRS
Copyright_xml	– notice: 2004 Elsevier Ltd – notice: 2005 INIST-CNRS
DBID	AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1016/j.bmcl.2004.11.049
DatabaseName	CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine Anatomy & Physiology Chemistry
EISSN	1464-3405
EndPage	593
ExternalDocumentID	15664818 16478183 10_1016_j_bmcl_2004_11_049 S0960894X04014192
Genre	Journal Article
GroupedDBID	--- --K --M .HR .~1 0R~ 1B1 1RT 1~. 1~5 23N 4.4 457 4G. 53G 5GY 5VS 6TJ 7-5 71M 8P~ 9JM 9JN AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARLI AATCM AAXUO ABBQC ABFNM ABGSF ABJNI ABLVK ABMAC ABMZM ABTAH ABUDA ABXDB ABYKQ ABZDS ACDAQ ACGFS ACIUM ACNNM ACRLP ADBBV ADECG ADEZE ADMUD ADUVX AEBSH AEHWI AEKER AENEX AFFNX AFKWA AFTJW AFXIZ AFZHZ AGHFR AGRDE AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJSZI ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 D0L DOVZS EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FLBIZ FNPLU FYGXN G-2 G-Q GBLVA HEA HMK HMO HMS HMT HVGLF HZ~ IHE J1W KOM LCYCR LZ2 M29 M2Z M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SAE SCB SCC SDF SDG SDP SES SEW SOC SPC SPCBC SPT SSH SSK SSP SSU SSZ T5K WUQ XFK XPP Y6R YK3 ZMT ZY4 ~02 ~G- 9DU AATTM AAXKI AAYWO AAYXX ABWVN ACIEU ACLOT ACRPL ACVFH ADCNI ADNMO ADXHL AEIPS AEUPX AFJKZ AFPUW AGQPQ AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP CITATION EFKBS ~HD AGCQF AGRNS IQODW CGR CUY CVF ECM EIF NPM PKN 7X8
ID	FETCH-LOGICAL-c428t-1c544c241454506ffb0ea364d5a0a1cef944fb379eaeffc54cda73fe74b3b4e43
ISICitedReferencesCount	11
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000226935700019&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0960-894X
IngestDate	Thu Oct 02 06:34:02 EDT 2025 Wed Feb 19 01:42:59 EST 2025 Mon Jul 21 09:15:14 EDT 2025 Tue Nov 18 22:18:27 EST 2025 Sat Nov 29 07:07:21 EST 2025 Fri Feb 23 02:23:04 EST 2024
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	3
Keywords	Nociception Opioid Analgesia ORL1 Agonist Intravenous administration Rodentia Selectivity In vitro In vivo Vertebrata Mammalia Analgesic Structure activity relation Mouse Benzimidazole derivatives N/OFQ receptor Animal Piperidine derivatives Chemical synthesis
Language	English
License	CC BY 4.0
LinkModel	OpenURL
MergedId	FETCHMERGED-LOGICAL-c428t-1c544c241454506ffb0ea364d5a0a1cef944fb379eaeffc54cda73fe74b3b4e43
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
OpenAccessLink	https://doi.org/10.7270/q2k35t50
PMID	15664818
PQID	67375113
PQPubID	23479
PageCount	5
ParticipantIDs	proquest_miscellaneous_67375113 pubmed_primary_15664818 pascalfrancis_primary_16478183 crossref_primary_10_1016_j_bmcl_2004_11_049 crossref_citationtrail_10_1016_j_bmcl_2004_11_049 elsevier_sciencedirect_doi_10_1016_j_bmcl_2004_11_049
PublicationCentury	2000
PublicationDate	2005-02-01
PublicationDateYYYYMMDD	2005-02-01
PublicationDate_xml	– month: 02 year: 2005 text: 2005-02-01 day: 01
PublicationDecade	2000
PublicationPlace	Oxford
PublicationPlace_xml	– name: Oxford – name: England
PublicationTitle	Bioorganic & medicinal chemistry letters
PublicationTitleAlternate	Bioorg Med Chem Lett
PublicationYear	2005
Publisher	Elsevier Ltd Elsevier
Publisher_xml	– name: Elsevier Ltd – name: Elsevier
References	6.8 Fawzi, Zhang, Weig, Hawes, Graziano, Corboz, Rivelli, Egan, Tulshian, Matasi, Fawzi, Benbow, Smith-Torhan, Zhang, Hey (bib5) 1997; 336 8.98 (1H, s, NH), 7.85 (1H, d), 7.17 (1H, m), 7.05 (2H, d), 7.03 (1H, s), 6.43 (2H, m), 4.70 (1H, m), 4.25 (1H, m), 3.82 (1H, m), 3.78 (3H, s, OMe), 3.65 (1H, m), 3.35 (2H, m), 3.15 (2H, m), 2.87 (2H, m), 2.40 (1H, m), 2.25 (1H, m), 2.14 (3H, s, Me), 2.09 (1H, m), 1.98 (2H, m), 0.99 (3H, d H NMR (CDCl Hz), 0.96 (3H, d Ronzoni, Peretto, Giardina, Long, Zaveri, Toll, Kolczewski, Adam, Cesura, Jenck, Hennig, Oberhauser, Poli, Roessler, Roever, Wichmann, Dautzenberg, Wu, Caplen, Domalski, Zhang, Fawzi, Burnett, Kawamoto, Nakashima, Kato, Arai, Kamata, Iwasawa (bib4) 2001; 11 Dubuisson, Dennis (bib12) 1977; 4 Mitsunobu (bib6) 1981; 1 (%): 438.2 [M+H] Mollereau, Parmentier, Mailleux, Butour, Moisand, Chalon, Caput, Vassart, Meunier, Kieth, Maung, Auton, Evans, Wick, Minnerath, Lin, Elde, Law, Loh, Wang, Johnson, Imai, Persico, Ozenberger, Eppler, Uhl (bib1) 1994; 361 H NMR. Analytical data for compound Ram, Spicer (bib10) 1988; 29 ) Guenter, Keese, Rimpler (bib8) 1985; 118 Richter, Walk, Hoeltzel, Jung (bib7) 1999; 64 / Meunier (bib3) 2000; 10 Bates, Donnelly, Keegan (bib9) 1991; 47 100 Reinscheid, Nothacker, Bourson, Ardati, Henningsen, Bunzow, Grandy, Langen, Monsma, Civelli, Meunier, Mollereau, Toll, Suaudeau, Moisand, Alvinerie, Butour, Guillemot, Fexrara, Monsarrat, Mazarguil, Vussart, Parmentier, Costentin (bib2) 1995; 270 Cowley, P. M.; Cottney, J.; Barn, D. R.; Morphy, J. R.; Palin, R.; Grove, S. J. A. WO 02/100861 A1, 2002. Compounds were characterised by MS and 400 Hz). Mass spectrum = MHz Dubuisson (10.1016/j.bmcl.2004.11.049_bib12) 1977; 4 Fawzi (10.1016/j.bmcl.2004.11.049_bib5_1) 1997; 336 10.1016/j.bmcl.2004.11.049_bib11 Kawamoto (10.1016/j.bmcl.2004.11.049_bib4_5) 2001; 57 Ronzoni (10.1016/j.bmcl.2004.11.049_bib4_1) 2001; 11 Bates (10.1016/j.bmcl.2004.11.049_bib9) 1991; 47 Wu (10.1016/j.bmcl.2004.11.049_bib4_4) 2002; 12 Ram (10.1016/j.bmcl.2004.11.049_bib10) 1988; 29 Wang (10.1016/j.bmcl.2004.11.049_bib1_4) 1994; 348 Reinscheid (10.1016/j.bmcl.2004.11.049_bib2_1) 1995; 270 Meunier (10.1016/j.bmcl.2004.11.049_bib3) 2000; 10 Kolczewski (10.1016/j.bmcl.2004.11.049_bib4_3) 2003; 46 Mitsunobu (10.1016/j.bmcl.2004.11.049_bib6) 1981; 1 Corboz (10.1016/j.bmcl.2004.11.049_bib5_2) 2000; 402 Long (10.1016/j.bmcl.2004.11.049_bib4_2) 2004; 14 Mollereau (10.1016/j.bmcl.2004.11.049_bib1_1) 1994; 361 Meunier (10.1016/j.bmcl.2004.11.049_bib2_2) 1995; 377 Kieth (10.1016/j.bmcl.2004.11.049_bib1_2) 1994; 54 Wick (10.1016/j.bmcl.2004.11.049_bib1_3) 1994; 27 Guenter (10.1016/j.bmcl.2004.11.049_bib8) 1985; 118 Richter (10.1016/j.bmcl.2004.11.049_bib7) 1999; 64
References_xml	– reference: (100%) – volume: 29 start-page: 3741 year: 1988 ident: bib10 publication-title: Tetrahedron Lett. – reference: H NMR. Analytical data for compound – reference: MHz – reference: / – volume: 1 start-page: 1 year: 1981 ident: bib6 publication-title: Synthesis – reference: 6.8 – volume: 4 start-page: 161 year: 1977 ident: bib12 publication-title: Pain – volume: 64 start-page: 1362 year: 1999 ident: bib7 publication-title: J. Org. Chem. – volume: 118 start-page: 4288 year: 1985 ident: bib8 publication-title: Chem. Ber. – volume: 47 start-page: 4991 year: 1991 ident: bib9 publication-title: Tetrahedron – reference: (%): 438.2 [M+H] – volume: 336 start-page: 233 year: 1997 ident: bib5 publication-title: Eur. J. Pharmacol. – reference: : 400 – reference: Hz), 0.96 (3H, d, – volume: 11 start-page: 525 year: 2001 ident: bib4 publication-title: Exp. Opin. Ther. Patents – reference: 8.98 (1H, s, NH), 7.85 (1H, d), 7.17 (1H, m), 7.05 (2H, d), 7.03 (1H, s), 6.43 (2H, m), 4.70 (1H, m), 4.25 (1H, m), 3.82 (1H, m), 3.78 (3H, s, OMe), 3.65 (1H, m), 3.35 (2H, m), 3.15 (2H, m), 2.87 (2H, m), 2.40 (1H, m), 2.25 (1H, m), 2.14 (3H, s, Me), 2.09 (1H, m), 1.98 (2H, m), 0.99 (3H, d, – volume: 270 start-page: 792 year: 1995 ident: bib2 publication-title: Science – volume: 10 start-page: 371 year: 2000 ident: bib3 publication-title: Exp. Opin. Ther. Patents – volume: 361 start-page: 33 year: 1994 ident: bib1 publication-title: FEBS Lett. – reference: = – reference: Hz). Mass spectrum – reference: Cowley, P. M.; Cottney, J.; Barn, D. R.; Morphy, J. R.; Palin, R.; Grove, S. J. A. WO 02/100861 A1, 2002. Compounds were characterised by MS and – reference: H NMR (CDCl – reference: ) – volume: 14 start-page: 181 year: 2004 ident: 10.1016/j.bmcl.2004.11.049_bib4_2 publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2003.09.068 – volume: 336 start-page: 233 year: 1997 ident: 10.1016/j.bmcl.2004.11.049_bib5_1 publication-title: Eur. J. Pharmacol. doi: 10.1016/S0014-2999(97)01227-2 – volume: 118 start-page: 4288 year: 1985 ident: 10.1016/j.bmcl.2004.11.049_bib8 publication-title: Chem. Ber. doi: 10.1002/cber.19851181037 – volume: 27 start-page: 37 year: 1994 ident: 10.1016/j.bmcl.2004.11.049_bib1_3 publication-title: Mol. Brain Res. doi: 10.1016/0169-328X(94)90181-3 – volume: 270 start-page: 792 year: 1995 ident: 10.1016/j.bmcl.2004.11.049_bib2_1 publication-title: Science doi: 10.1126/science.270.5237.792 – volume: 11 start-page: 525 year: 2001 ident: 10.1016/j.bmcl.2004.11.049_bib4_1 publication-title: Exp. Opin. Ther. Patents doi: 10.1517/13543776.11.4.525 – volume: 377 start-page: 532 year: 1995 ident: 10.1016/j.bmcl.2004.11.049_bib2_2 publication-title: Nature doi: 10.1038/377532a0 – volume: 1 start-page: 1 year: 1981 ident: 10.1016/j.bmcl.2004.11.049_bib6 publication-title: Synthesis doi: 10.1055/s-1981-29317 – volume: 46 start-page: 255 year: 2003 ident: 10.1016/j.bmcl.2004.11.049_bib4_3 publication-title: J. Med. Chem. doi: 10.1021/jm0209174 – volume: 29 start-page: 3741 year: 1988 ident: 10.1016/j.bmcl.2004.11.049_bib10 publication-title: Tetrahedron Lett. doi: 10.1016/S0040-4039(00)82103-6 – volume: 12 start-page: 3157 year: 2002 ident: 10.1016/j.bmcl.2004.11.049_bib4_4 publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/S0960-894X(02)00652-2 – volume: 348 start-page: 75 year: 1994 ident: 10.1016/j.bmcl.2004.11.049_bib1_4 publication-title: FEBS Lett. doi: 10.1016/0014-5793(94)00557-5 – volume: 47 start-page: 4991 year: 1991 ident: 10.1016/j.bmcl.2004.11.049_bib9 publication-title: Tetrahedron doi: 10.1016/S0040-4020(01)80962-5 – volume: 54 start-page: 143 year: 1994 ident: 10.1016/j.bmcl.2004.11.049_bib1_2 publication-title: Regul. Pept. doi: 10.1016/0167-0115(94)90431-6 – volume: 361 start-page: 33 year: 1994 ident: 10.1016/j.bmcl.2004.11.049_bib1_1 publication-title: FEBS Lett. doi: 10.1016/0014-5793(94)80235-1 – volume: 4 start-page: 161 year: 1977 ident: 10.1016/j.bmcl.2004.11.049_bib12 publication-title: Pain doi: 10.1016/0304-3959(77)90130-0 – volume: 402 start-page: 171 year: 2000 ident: 10.1016/j.bmcl.2004.11.049_bib5_2 publication-title: Eur. J. Pharmacol. doi: 10.1016/S0014-2999(00)00505-7 – volume: 10 start-page: 371 year: 2000 ident: 10.1016/j.bmcl.2004.11.049_bib3 publication-title: Exp. Opin. Ther. Patents doi: 10.1517/13543776.10.4.371 – volume: 57 start-page: 981 year: 2001 ident: 10.1016/j.bmcl.2004.11.049_bib4_5 publication-title: Tetrahedron doi: 10.1016/S0040-4020(00)01064-4 – volume: 64 start-page: 1362 year: 1999 ident: 10.1016/j.bmcl.2004.11.049_bib7 publication-title: J. Org. Chem. doi: 10.1021/jo981582u – ident: 10.1016/j.bmcl.2004.11.049_bib11
SSID	ssj0014044
Score	1.8016945
Snippet	A series of potent and soluble ORL1 agonists was prepared and evaluated. Compound 41 showed antinociceptive properties in mouse formalin paw test (ED 50 = 1.07... A series of 3-phenoxypropyl piperidine analogues have been discovered as novel ORL1 receptor agonists. Structure-activity relationships have been explored...
SourceID	proquest pubmed pascalfrancis crossref elsevier
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	589
SubjectTerms	Analgesia Analgesics Animals Biological and medical sciences CHO Cells Cricetinae Cyclic AMP - biosynthesis Drug Design Humans Hydrophobic and Hydrophilic Interactions Inhibitory Concentration 50 Male Medical sciences Mice Neuropharmacology Nociception Opioid ORL1 Pharmacology. Drug treatments Piperidines - chemical synthesis Piperidines - pharmacology Receptors, Opioid - agonists Structure-Activity Relationship Transfection Vas Deferens
Title	Synthesis and SAR studies of 3-phenoxypropyl piperidine analogues as ORL1 (NOP) receptor agonists
URI	https://dx.doi.org/10.1016/j.bmcl.2004.11.049 https://www.ncbi.nlm.nih.gov/pubmed/15664818 https://www.proquest.com/docview/67375113
Volume	15
WOSCitedRecordID	wos000226935700019&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1464-3405 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0014044 issn: 0960-894X databaseCode: AIEXJ dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1db9MwFLW6DQESQtANKB_DDwiBqkzN4tTJY1UVwQRbVYbUt8hxbdSpTaIlm9q_wS_m-itZhzrBAy9R1ThJ1XN8c-_18b0IvYtoGvgMJhLY39gjIRMeg4nhRTFLGbzwCA25bjZBT0-j6TQet1q_3F6Y6wXNsmi1iov_CjV8B2CrrbP_AHd9U_gCPgPocATY4fhXwH9fZ-DUqTojWpU5mOgSsnNTXDbwlKYrX6mNTsV60S3mqtLxTLmaLDN5nFK1njmbfPV1o56zscobgFkURaX0lj9zVWq33FgLnuemNxTXPLKr9aruiGsm113oTUO1-z5mtk38RGemm2yqURZrnX2jZNQSIicbbtKyw7yqrFTtRC0njDYSGKHTPDeZyH4PuGGEmrVRDm-QL7hhYUPTcegPy2-SEBdH6ZLrFSVypIqzko3BAFSx1LCrqJVE1vJv1tt2p3bQ3jENY7CUe4Mvo-lJvTZFerpFcP2z7VYsoxq8_Xjd9snccJvn86hgJcxHaRqpbI90tMdz_gQ9tqEKHhiKPUUtkbXR_iBjVb5c4_dYi4f1qkwbPRg6rNvo_jer19hHrCYjBjJiICO2ZMS5xLfIiBsy4pqMmJVYkRF_ACp-xI6I2BHxAP34NDoffvZsUw-PQ6RbeT4PCeHgNxLw3Xt9KdOeYEGfzELWYz4XMiZEpgGNBRNSwmA-YzSQgpI0SIkgwTO0m-WZeIEwmB-mXuZCpQWoPI79OJLxLKQqRpd93kG--8MTbiveq8Yri8RJGy8ShZdqxUogFE4Arw7q1tcUpt7LnaNDh2NiPVbjiSZAyzuvO9wAvXmU3vodBR301rEgAfTUIh7LRH5VKh0mhSAJRjw35GiutTx7ufXMK_SwmYCv0W51eSXeoHv8upqXl4doh06jQ8v23yFVzVA
linkProvider	Elsevier
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synthesis+and+SAR+studies+of+3-phenoxypropyl+piperidine+analogues+as+ORL1+%28NOP%29+receptor+agonists&rft.jtitle=Bioorganic+%26+medicinal+chemistry+letters&rft.au=Palin%2C+Ronald&rft.au=Barn%2C+David+R&rft.au=Clark%2C+John+K&rft.au=Cottney%2C+Jean+E&rft.date=2005-02-01&rft.issn=0960-894X&rft.volume=15&rft.issue=3&rft.spage=589&rft_id=info:doi/10.1016%2Fj.bmcl.2004.11.049&rft_id=info%3Apmid%2F15664818&rft.externalDocID=15664818
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0960-894X&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0960-894X&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0960-894X&client=summon